Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08844_nanopub.RAs0hEeiy4-a1KEZS65VCkKdx247GAHyqrDIA620S-l80#assertion>. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB08844 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08844 label "Uric Acid [drugbank:DB08844]" assertion.
- drugbank:DB08844 seeAlso DB08844 assertion.
- drugbank:DB08844 identifier "drugbank:DB08844" assertion.
- drugbank:DB08844 description "Uric acid is the last product of purine metabolism in humans. The formation of uric acid is through the enzyme xanthine oxidase, which oxidizes oxypurines. Normally a small amount of uric acid is present in the body, but when there is an excess amount in the blood, called hyperuricemia, this can lead to gout and formation of kidney stones. As a therapeutic agent, it is known that uric acid is increased in response to oxidative stress, and as such, uric acid acts as an antioxidant. At present (August 2013), there is no approved formulation or indication for uric acid. In one country, Spain, uric acid is an investigational drug in a phase 3 trial studying its effects as an adjunct to alteplase in acute ischemic stroke." assertion.
- drugbank:DB08844 title "Uric Acid" assertion.
- drugbank:DB08844 bio2rdf_vocabulary:identifier "DB08844" assertion.
- drugbank:DB08844 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08844 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08844" assertion.
- drugbank:DB08844 bio2rdf_vocabulary:x-identifiers.org DB08844 assertion.
- drugbank:DB08844 drugbank_vocabulary:drugbank-id "DB01696" assertion.
- drugbank:DB08844 drugbank_vocabulary:drugbank-id "DB08844" assertion.
- drugbank:DB08844 drugbank_vocabulary:x-cas cas:69-93-2 assertion.
- drugbank:DB08844 drugbank_vocabulary:x-chebi chebi:17775 assertion.
- drugbank:DB08844 drugbank_vocabulary:x-kegg kegg:C00366 assertion.
- drugbank:DB08844 drugbank_vocabulary:x-wikipedia wikipedia:Uric_acid assertion.